Patient Admitted with Ebola Virus Discharged from NIH Clinical Center
UPDATED April 9, 5:44 p.m. The American healthcare worker admitted to the NIH Clinical Center on March 13 with the Ebola virus was discharged today in good condition after having been successfully treated at the NIH Clinical Center Special Clinical Studies Unit.
According to NIH officials, the individual is no longer contagious to the community.
No other information is being released about the patient.
UPDATED April 7, 12 p.m. In a statement released today, NIH officials have upgraded the condition of the patient with the Ebola virus from fair condition to good condition. No other information is being released at this time.
UPDATED March 26, 2 p.m. – The status of the healthcare worker with the Ebola virus who is being treated at the NIH Clinical Center has improved from critical to serious condition, according to a March 26th update from NIH. No additional info has been released.
UPDATED, March 16, 1:45 p.m. – The healthcare worker being treated at the NIH Clinical Center in Bethesda for the Ebola virus is now listed in critical condition.
The NIH released the information on Monday. The healthcare worker was previously listed as being in serious condition. No additional details about the patient are being released. The NIH has no pending admissions of additional individuals with Ebola virus disease or exposed to the Ebola virus.
UPDATED The National Institutes of Health (NIH) has admitted to its hospital an American healthcare worker who has tested positive for the Ebola virus.
According to a news release, the healthcare worker was volunteering services in an Ebola treatment unit in Sierra Leone and was transported back to the United States in isolation via a chartered aircraft on Friday morning. NIH physicians have evaluated the patient and determined the patient’s condition is serious.
NIH officials said the individual is being treated at the NIH Clinical Center Special Clinical Studies Unit in Bethesda, a high-level containment facility which is one of a small number of such facilities in the United States.
No additional details about the patient are being released at this time.
According to NIH, the Clinical Center’s Special Clinical Studies Unit (SCSU) is specifically designed to provide high-level isolation capabilities and is staffed by infectious diseases and critical care specialists. The unit staff is trained in strict infection control practices optimized to prevent spread of potentially transmissible agents such as Ebola. In addition, access to the unit is strictly controlled. NIH officials said they are taking every precaution to ensure the safety of patients, NIH staff and the public.
This will be the second patient with Ebola virus disease admitted to the NIH Clinical Center. An earlier patient was treated successfully and released free of disease. The NIH Clinical Center also admitted two individuals who experienced high-risk exposures to the Ebola virus while working on the Ebola response in West Africa, but who were ultimately found not to be infected.